Advanced Polymer Systems Expands Licensing Agreement with Dermik Laboratories

Strategic Insights -

Advanced Polymer Systems, Inc. announced that its partner, Dermik Laboratories, Inc., has initiated Phase III studies of a product containing Microsponge(R)-entrapped 5-fluorouracil (5-FU) for the treatment of actinic keratosis, a common precancerous skin condition. The formulation utilizes Advanced Polymer's proprietary Microsponge technology to deliver 5-FU with reduced irritation.

As part of the expanded agreement, Dermik Laboratories has secured exclusive worldwide rights to Microsponge-entrapped 5-FU. In return, Advanced Polymer will receive increased royalties. The expansion of this agreement will enable Dermik Laboratories to commercialize this formulation on a worldwide basis.

Key Takeaways:

  • Advanced Polymer Systems has partnered with Dermik Laboratories to develop a product containing Microsponge(R)-entrapped 5-fluorouracil (5-FU) for the treatment of actinic keratosis.
  • The formulation utilizes Advanced Polymer's proprietary Microsponge technology to deliver 5-FU with reduced irritation.
  • Dermik Laboratories has initiated Phase III studies of this product, which will be conducted at 20 centers throughout the U.S.
  • The expanded agreement secures exclusive worldwide rights to Microsponge-entrapped 5-FU for Dermik Laboratories in return for increased royalties for Advanced Polymer.
  • Advanced Polymer will receive increased royalties from the expanded agreement.
  • Advanced Polymer's Microsponge technology is used in almost 100 personal care products sold worldwide.
  • The company is developing new products and technologies, including site-specific systems for delivering oral medications to the lower gastrointestinal tract.
  • The expansion of this agreement reflects Advanced Polymer's commitment to developing a broad range of novel drug delivery systems and commercializing them with world-class partners.
  • Dermik Laboratories is an independently managed strategic business unit within Rhone-Poulenc Rorer, Inc.
  • Advanced Polymer Systems is a leader in polymer-based delivery systems and related technologies used primarily for skin care in ethical and over-the-counter (OTC) pharmaceuticals and personal care products.

Statistics:

  • 20: The number of centers where the Phase III studies will be conducted.
  • Almost 100: The number of personal care products sold worldwide that utilize Advanced Polymer's Microsponge and Polytrap(R) systems.
  • 5-Fluorouracil (5-FU): The active ingredient used in the new product.
  • Actinic keratosis: The common precancerous skin condition being targeted by the new product.

Sources:

  • PRNewswire: "Advanced Polymer Systems Announces Expansion of Licensing Agreement with Dermik Laboratories"
  • Advanced Polymer Systems, Inc.: "Advanced Polymer Systems Announces Expansion of Licensing Agreement with Dermik Laboratories"
  • Rhone-Poulenc Rorer, Inc.: "Dermik Laboratories"
  • Advanced Polymer Systems, Inc.: "Advanced Polymer Systems"